AbCellera Biologics Inc. - Common Shares (NQ:ABCL)
All News about AbCellera Biologics Inc. - Common Shares



Via Business Wire




AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
Via Business Wire







Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga







AbCellera Reports Q3 2022 Business Results
November 08, 2022
Via Business Wire

AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
Via Business Wire






Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.